Aprea Therapeutics records second consecutive surge, jumping another 22%
What it means
- What to watch: This one turns on a concrete figure (22%); set it against the recent trend before reading it as a turning point.
- How the stock is trading: $APRE -1.90% in the latest session.
- Timing: It landed while New York was open, so the session move beside it may include the reaction.
Where the stock stands
$APRE last traded at $0.51, -1.90% on the session. That is 66% below its 52-week high of $1.49 and 23% above its low of $0.41 — within a tenth of its 52-week low. Over the year it has ranged 263% from low to high: a very wide band for one year, the kind of volatility where large swings are routine. These are latest-session quotes, not live prices — the live tape is on the $APRE page.
How much coverage it is getting
This is the only story Wook has logged on $APRE in the last 30 days, so there is no run to measure it against yet. 12 related stories — same name or same desk — are lined up beside this one if you want the whole thread.
The bigger picture
In healthcare, the calendar is the catalyst — trial readouts, FDA decisions and pricing rules. One result can move a single drugmaker sharply; a policy change moves the whole aisle. On Wook's supply-chain scanner, Health Care reads calm today — no unusual stress in the filings and disclosures it watches.
Coming up
$APRE earnings in 6 days. These were on the calendar before this story and are not caused by it, but the nearest is close enough that the next hard numbers on this company will arrive soon.
What to watch next
The $APRE page has the full chart, the filings and the valuation model behind these figures. Because one outlet dominates the coverage, reading another outlet on the same story is the quickest check on whether it is being confirmed or just repeated. Wook AI, above, can pull live figures and do the math — how far $APRE is from its high, or how this week's coverage compares — on request.
How this analysis was made
Seeking Alpha published it, and Wook filed it under Healthcare & Pharma. It reads bullish at high severity because of “surge”, “record” and “jump” in the wording, with nothing on the bearish side to offset them. It was matched to $APRE. It carried 22%, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Seeking Alpha published this on August 25, 2026. $APRE has moved -48.45% ($0.98 to $0.51). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.